0
Your cart

Your cart is empty

Books > Medicine > General issues > Public health & preventive medicine > Epidemiology & medical statistics

Buy Now

Interface between Regulation and Statistics in Drug Development (Hardcover) Loot Price: R4,092
Discovery Miles 40 920
Interface between Regulation and Statistics in Drug Development (Hardcover): Demissie Alemayehu, Birol Emir, Michael Gaffney

Interface between Regulation and Statistics in Drug Development (Hardcover)

Demissie Alemayehu, Birol Emir, Michael Gaffney

Series: Chapman & Hall/CRC Biostatistics Series

 (sign in to rate)
Loot Price R4,092 Discovery Miles 40 920 | Repayment Terms: R383 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

With the critical role of statistics in the design, conduct, analysis and reporting of clinical trials or observational studies intended for regulatory purposes, numerous guidelines have been issued by regulatory authorities around the world focusing on statistical issues related to drug development. However, the available literature on this important topic is sporadic, and often not readily accessible to drug developers or regulatory personnel. This book provides a systematic exposition of the interplay between the two disciplines, including emerging themes pertaining to the acceleration of the development of pharmaceutical medicines to serve patients with unmet needs. Features: Regulatory and statistical interactions throughout the drug development continuum The critical role of the statistician in relation to the changing regulatory and healthcare landscapes Statistical issues that commonly arise in the course of drug development and regulatory interactions Trending topics in drug development, with emphasis on current regulatory thinking and the associated challenges and opportunities The book is designed to be accessible to readers with an intermediate knowledge of statistics, and can be a useful resource to statisticians, medical researchers, and regulatory personnel in drug development, as well as graduate students in the health sciences. The authors' decades of experience in the pharmaceutical industry and academia, and extensive regulatory experience, comes through in the many examples throughout the book.

General

Imprint: Crc Press
Country of origin: United Kingdom
Series: Chapman & Hall/CRC Biostatistics Series
Release date: November 2020
First published: 2021
Authors: Demissie Alemayehu • Birol Emir • Michael Gaffney
Dimensions: 234 x 156 x 11mm (L x W x T)
Format: Hardcover
Pages: 146
ISBN-13: 978-0-367-49048-5
Categories: Books > Science & Mathematics > Mathematics > Probability & statistics
Books > Science & Mathematics > Biology, life sciences > General
Books > Medicine > General issues > Medical equipment & techniques > Medical research
Books > Medicine > General issues > Public health & preventive medicine > Epidemiology & medical statistics
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
Promotions
LSN: 0-367-49048-X
Barcode: 9780367490485

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners